- Home
- LWLG vs LXEO Comparison
LWLG vs LXEO Comparison
Compare LWLG & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LWLG
- LXEO
- Stock Information
- Founded
- LWLG 1991
- LXEO 2017
- Country
- LWLG United States
- LXEO United States
- Employees
- LWLG N/A
- LXEO N/A
- Industry
- LWLG Containers/Packaging
- LXEO
- Sector
- LWLG Industrials
- LXEO
- Exchange
- LWLG Nasdaq
- LXEO Nasdaq
- Market Cap
- LWLG 126.0M
- LXEO 140.6M
- IPO Year
- LWLG N/A
- LXEO 2023
- Fundamental
- Price
- LWLG $1.04
- LXEO $3.47
- Analyst Decision
- LWLG
- LXEO Strong Buy
- Analyst Count
- LWLG 0
- LXEO 5
- Target Price
- LWLG N/A
- LXEO $22.80
- AVG Volume (30 Days)
- LWLG 910.1K
- LXEO 894.5K
- Earning Date
- LWLG 03-18-2025
- LXEO 03-24-2025
- Dividend Yield
- LWLG N/A
- LXEO N/A
- EPS Growth
- LWLG N/A
- LXEO N/A
- EPS
- LWLG N/A
- LXEO N/A
- Revenue
- LWLG $95,605.00
- LXEO N/A
- Revenue This Year
- LWLG N/A
- LXEO N/A
- Revenue Next Year
- LWLG N/A
- LXEO N/A
- P/E Ratio
- LWLG N/A
- LXEO N/A
- Revenue Growth
- LWLG 136.05
- LXEO N/A
- 52 Week Low
- LWLG $0.98
- LXEO $2.32
- 52 Week High
- LWLG $4.82
- LXEO $19.50
- Technical
- Relative Strength Index (RSI)
- LWLG 41.23
- LXEO 48.25
- Support Level
- LWLG $0.98
- LXEO $3.75
- Resistance Level
- LWLG $1.31
- LXEO $4.59
- Average True Range (ATR)
- LWLG 0.11
- LXEO 0.50
- MACD
- LWLG 0.02
- LXEO 0.18
- Stochastic Oscillator
- LWLG 15.56
- LXEO 47.17
About LWLG Lightwave Logic Inc.
Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.